These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 26465832)
1. Lamotrigine Augmentation in Treatment-Resistant Pediatric Obsessive-Compulsive Disorder with a 16 Month Follow-up. Naguy A; Alamiri B; Al-Khadhari S; Francis K J Child Adolesc Psychopharmacol; 2016 Oct; 26(8):769-772. PubMed ID: 26465832 [No Abstract] [Full Text] [Related]
2. Lamotrigine augmentation of serotonin reuptake inhibitors in treatment-resistant obsessive-compulsive disorder: a double-blind, placebo-controlled study. Bruno A; Micò U; Pandolfo G; Mallamace D; Abenavoli E; Di Nardo F; D'Arrigo C; Spina E; Zoccali RA; Muscatello MR J Psychopharmacol; 2012 Nov; 26(11):1456-62. PubMed ID: 22351381 [TBL] [Abstract][Full Text] [Related]
3. Lamotrigine augmentation of serotonin re-uptake inhibitors in obsessive-compulsive disorder. Kumar TC; Khanna S Aust N Z J Psychiatry; 2000 Jun; 34(3):527-8. PubMed ID: 10881981 [No Abstract] [Full Text] [Related]
4. Augmentation agents to serotonin reuptake inhibitors for treatment-resistant obsessive-compulsive disorder: A network meta-analysis. Zhou DD; Zhou XX; Li Y; Zhang KF; Lv Z; Chen XR; Wan LY; Wang W; Wang GM; Li DQ; Ai M; Kuang L Prog Neuropsychopharmacol Biol Psychiatry; 2019 Mar; 90():277-287. PubMed ID: 30576763 [TBL] [Abstract][Full Text] [Related]
6. Early augmentation in the management of obsessive-compulsive disorder. Kar SK Asian J Psychiatr; 2022 Mar; 69():103005. PubMed ID: 34998234 [No Abstract] [Full Text] [Related]
7. [Trichotillomania and comorbidity--lamotrigine in a new perspective]. Moretti M Neuropsychopharmacol Hung; 2008 Oct; 10(4):201-12. PubMed ID: 19213199 [TBL] [Abstract][Full Text] [Related]
8. Olanzapine addition in obsessive-compulsive disorder refractory to selective serotonin reuptake inhibitors: an open-label case series. Weiss EL; Potenza MN; McDougle CJ; Epperson CN J Clin Psychiatry; 1999 Aug; 60(8):524-7. PubMed ID: 10485634 [TBL] [Abstract][Full Text] [Related]
13. Pregabalin augmentation in treatment-resistant obsessive-compulsive disorder: a 16-week case series. Di Nicola M; Tedeschi D; Martinotti G; De Vita O; Monetta M; Pozzi G; Janiri L J Clin Psychopharmacol; 2011 Oct; 31(5):675-7. PubMed ID: 21881460 [No Abstract] [Full Text] [Related]
14. A Systematic Review of Evidence-based Treatment Strategies for Obsessive- compulsive Disorder Resistant to first-line Pharmacotherapy. Albert U; Marazziti D; Di Salvo G; Solia F; Rosso G; Maina G Curr Med Chem; 2018; 25(41):5647-5661. PubMed ID: 29278206 [TBL] [Abstract][Full Text] [Related]
15. Risperidone augmentation of paroxetine in a case of severe, treatment-refractory obsessive-compulsive disorder without comorbid psychopathology. Agid O; Lerer B J Clin Psychiatry; 1999 Jan; 60(1):55-6. PubMed ID: 10074882 [No Abstract] [Full Text] [Related]
16. Addition of desipramine to serotonin reuptake inhibitors in treatment-resistant obsessive-compulsive disorder. Barr LC; Goodman WK; Anand A; McDougle CJ; Price LH Am J Psychiatry; 1997 Sep; 154(9):1293-5. PubMed ID: 9286191 [TBL] [Abstract][Full Text] [Related]
17. Minocycline augmentation of pharmacotherapy in obsessive-compulsive disorder: an open-label trial. Rodriguez CI; Bender J; Marcus SM; Snape M; Rynn M; Simpson HB J Clin Psychiatry; 2010 Sep; 71(9):1247-9. PubMed ID: 20923629 [TBL] [Abstract][Full Text] [Related]
18. Double-blind, placebo-controlled, pilot trial of paliperidone augmentation in serotonin reuptake inhibitor-resistant obsessive-compulsive disorder. Storch EA; Goddard AW; Grant JE; De Nadai AS; Goodman WK; Mutch PJ; Medlock C; Odlaug B; McDougle CJ; Murphy TK J Clin Psychiatry; 2013 Jun; 74(6):e527-32. PubMed ID: 23842022 [TBL] [Abstract][Full Text] [Related]
19. Antipsychotic Augmentation of Serotonin Reuptake Inhibitors in Treatment-Resistant Obsessive-Compulsive Disorder: An Update Meta-Analysis of Double-Blind, Randomized, Placebo-Controlled Trials. Dold M; Aigner M; Lanzenberger R; Kasper S Int J Neuropsychopharmacol; 2015 May; 18(9):. PubMed ID: 25939614 [TBL] [Abstract][Full Text] [Related]
20. Quetiapine augmentation in obsessive-compulsive disorder resistant to serotonin reuptake inhibitors: an open-label study. Bogan AM; Koran LM; Chuong HW; Vapnik T; Bystritsky A J Clin Psychiatry; 2005 Jan; 66(1):73-9. PubMed ID: 15669891 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]